Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
34
GRVY Quote, Financials, Valuation and Earnings
Last price:
$61.79
Seasonality move
:
12.94%
Day range:
$60.75 - $61.96
52-week range:
$57.37 - $88.85
Dividend yield:
0%
P/E ratio:
6.92x
P/S ratio:
1.12x
P/B ratio:
1.06x
Volume:
23.1K
Avg. volume:
30.7K
1-year change:
-12.7%
Market cap:
$430.4M
Revenue:
$555.2M
EPS (TTM):
$8.95
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $309.7M | $342.4M | $361.6M | $360.2M | $555.2M | |
| Revenue Growth (YoY) | 19.05% | 10.54% | 5.62% | -0.39% | 54.12% | |
| Cost of Revenues | $228.1M | $201.6M | $195.8M | $207.7M | $371.1M | |
| Gross Profit | $81.7M | $140.8M | $165.8M | $152.5M | $184.1M | |
| Gross Profit Margin | 26.37% | 41.12% | 45.84% | 42.33% | 33.16% | |
| R&D Expenses | $8.2M | $12.7M | $14.5M | $10.7M | $10.3M | |
| Selling, General & Admin | $30.3M | $50.9M | $63.4M | $57.1M | $47M | |
| Other Inc / (Exp) | $917.3K | -$2M | $409.7K | $517.5K | -$2.8M | |
| Operating Expenses | $39.8M | $65.3M | $80.6M | $71M | $60.9M | |
| Operating Income | $41.9M | $75.5M | $85.2M | $81.5M | $123.2M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $44M | $74.2M | $86.8M | $85.4M | $129.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $9.9M | $21.5M | $29.2M | $20.8M | $28.1M | |
| Net Income to Company | $34.1M | $52.8M | $57.6M | $64.5M | $101M | |
| Minority Interest in Earnings | $125.3K | $124K | $58.5K | $80.8K | $28.3K | |
| Net Income to Common Excl Extra Items | $34.2M | $52.9M | $57.6M | $64.6M | $101M | |
| Basic EPS (Cont. Ops) | $4.92 | $7.61 | $8.29 | $9.30 | $14.54 | |
| Diluted EPS (Cont. Ops) | $4.92 | $7.61 | $8.29 | $9.30 | $14.54 | |
| Weighted Average Basic Share | $6.9M | $6.9M | $6.9M | $6.9M | $6.9M | |
| Weighted Average Diluted Share | $6.9M | $6.9M | $6.9M | $6.9M | $6.9M | |
| EBITDA | $47.4M | $78.5M | $92.4M | $91M | $135.1M | |
| EBIT | $44.2M | $74.4M | $86.9M | $85.5M | $129.2M | |
| Revenue (Reported) | $309.7M | $342.4M | $361.6M | $360.2M | $555.2M | |
| Operating Income (Reported) | $41.9M | $75.5M | $85.2M | $81.5M | $123.2M | |
| Operating Income (Adjusted) | $44.2M | $74.4M | $86.9M | $85.5M | $129.2M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $110.8M | $110.9M | $76.4M | $134M | $94.7M | |
| Revenue Growth (YoY) | 70.79% | 0.1% | -31.11% | 75.4% | -29.37% | |
| Cost of Revenues | $62.3M | $57M | $44.7M | $89.7M | $56.2M | |
| Gross Profit | $48.5M | $53.9M | $31.8M | $44.4M | $38.4M | |
| Gross Profit Margin | 43.77% | 48.59% | 41.56% | 33.1% | 40.6% | |
| R&D Expenses | $3.8M | $3.6M | $2.8M | $3M | $2.7M | |
| Selling, General & Admin | $15.2M | $15.6M | $13.2M | $13.1M | $15M | |
| Other Inc / (Exp) | -- | -- | -- | $578.4K | -$374.7K | |
| Operating Expenses | $19.6M | $19.2M | $15.9M | $16.1M | $17.7M | |
| Operating Income | $28.9M | $34.7M | $15.9M | $28.3M | $20.7M | |
| Net Interest Expenses | $572.7K | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $28.3M | $35.7M | $18.2M | $31.4M | $21M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $7.1M | $13.1M | $6.2M | $9.3M | $4.5M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$3.4K | $57.8K | -$16.4K | -$18.3K | $36.9K | |
| Net Income to Common Excl Extra Items | $21.3M | $22.7M | $12M | $22M | $16.5M | |
| Basic EPS (Cont. Ops) | $3.06 | $3.27 | $1.73 | $3.17 | $2.38 | |
| Diluted EPS (Cont. Ops) | $3.06 | $3.27 | $1.73 | $3.17 | $2.38 | |
| Weighted Average Basic Share | $6.9M | $6.9M | $6.9M | $6.9M | $6.9M | |
| Weighted Average Diluted Share | $6.9M | $6.9M | $6.9M | $6.9M | $6.9M | |
| EBITDA | $29.6M | $36.5M | $19.9M | $34.2M | $24.7M | |
| EBIT | $29.6M | $36.5M | $19.9M | $34.2M | $24.7M | |
| Revenue (Reported) | $110.8M | $110.9M | $76.4M | $134M | $94.7M | |
| Operating Income (Reported) | $28.9M | $34.7M | $15.9M | $28.3M | $20.7M | |
| Operating Income (Adjusted) | $29.6M | $36.5M | $19.9M | $34.2M | $24.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $305.7M | $378M | $308M | $575.2M | $384.4M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $189.1M | $206.3M | $168.4M | $382.9M | $237.6M | |
| Gross Profit | $116.6M | $171.7M | $139.6M | $192.3M | $146.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $11.3M | $14.7M | $11.4M | $10.3M | $11.4M | |
| Selling, General & Admin | $52M | $55.8M | $68.3M | $47.5M | $59.3M | |
| Other Inc / (Exp) | -- | -- | -- | $578.4K | -$3.7M | |
| Operating Expenses | $64.1M | $70.9M | $79.8M | $61M | $73.9M | |
| Operating Income | $52.5M | $100.8M | $59.8M | $131.2M | $72.9M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $52.5M | $102.1M | $64.7M | $137.9M | $79.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $12.6M | $32M | $24.3M | $28.5M | $17.7M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | $71.3K | $85.8K | $149.1K | -$15.9K | $40.3K | |
| Net Income to Common Excl Extra Items | $40M | $70.2M | $40.6M | $109.4M | $62.2M | |
| Basic EPS (Cont. Ops) | $5.76 | $10.10 | $5.84 | $15.74 | $8.95 | |
| Diluted EPS (Cont. Ops) | $5.76 | $10.10 | $5.84 | $15.74 | $8.95 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | $55.5M | $105M | $69.2M | $140.4M | $80.8M | |
| EBIT | $55.5M | $105M | $69.2M | $140.4M | $80.8M | |
| Revenue (Reported) | $305.7M | $378M | $308M | $575.2M | $384.4M | |
| Operating Income (Reported) | $52.5M | $100.8M | $59.8M | $131.2M | $72.9M | |
| Operating Income (Adjusted) | $55.5M | $105M | $69.2M | $140.4M | $80.8M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $244.7M | $279.7M | $226.5M | $445.3M | $274.3M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $145.2M | $149.5M | $122.3M | $300.5M | $167M | |
| Gross Profit | $99.6M | $130.2M | $104.2M | $144.8M | $107.4M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $8.9M | $10.9M | $7.8M | $7.5M | $8.6M | |
| Selling, General & Admin | $38.9M | $42M | $44.6M | $34.9M | $47.3M | |
| Other Inc / (Exp) | -- | -- | -- | $578.4K | -$374.7K | |
| Operating Expenses | $48.6M | $53.3M | $52.2M | $42.4M | $55.5M | |
| Operating Income | $50.9M | $76.9M | $51.9M | $102.4M | $51.8M | |
| Net Interest Expenses | $572.7K | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $51.1M | $78.7M | $56.4M | $109.6M | $60M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $11.4M | $21.7M | $17M | $24.7M | $14.2M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | $54.3K | $15K | $108.6K | $4K | $15.4K | |
| Net Income to Common Excl Extra Items | $39.8M | $57M | $39.5M | $84.9M | $45.9M | |
| Basic EPS (Cont. Ops) | $5.72 | $8.21 | $5.68 | $12.22 | $6.60 | |
| Diluted EPS (Cont. Ops) | $5.72 | $8.21 | $5.68 | $12.22 | $6.60 | |
| Weighted Average Basic Share | $20.8M | $20.8M | $20.8M | $20.8M | $20.8M | |
| Weighted Average Diluted Share | $20.8M | $20.8M | $20.8M | $20.8M | $20.8M | |
| EBITDA | $53.4M | $80.7M | $60.5M | $115.8M | $67M | |
| EBIT | $53.4M | $80.7M | $60.5M | $115.8M | $67M | |
| Revenue (Reported) | $244.7M | $279.7M | $226.5M | $445.3M | $274.3M | |
| Operating Income (Reported) | $50.9M | $76.9M | $51.9M | $102.4M | $51.8M | |
| Operating Income (Adjusted) | $53.4M | $80.7M | $60.5M | $115.8M | $67M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $68.5M | $101.4M | $83.2M | $134.5M | $142.8M | |
| Short Term Investments | $34.3M | $65.9M | $124.8M | $134.9M | $218.6M | |
| Accounts Receivable, Net | $27.8M | $54.8M | $44.2M | $61.2M | $55.3M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $1.7M | $2.1M | $2.7M | $2.6M | $2.3M | |
| Other Current Assets | $2.1M | $2M | $1.3M | $626.5K | $2.6M | |
| Total Current Assets | $134.5M | $226.1M | $257.2M | $334M | $424.4M | |
| Property Plant And Equipment | $5.8M | $7.1M | $9.5M | $6.4M | $7.9M | |
| Long-Term Investments | $1.5M | $1.2M | $2.5M | $1.7M | $1.4M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $1.5M | $3.1M | $2.8M | $3.1M | $4.9M | |
| Other Long-Term Assets | $1.5M | $2.6M | $1.7M | $353.2K | $524.6K | |
| Total Assets | $151.4M | $243.3M | $275.1M | $351.7M | $448.7M | |
| Accounts Payable | $32.4M | $48.3M | $34.6M | $58.3M | $47.9M | |
| Accrued Expenses | $1M | $1.3M | $1.2M | $1.6M | $1.8M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $1.7M | $2.4M | $3M | $2.3M | $3.3M | |
| Total Current Liabilities | $48.1M | $75.9M | $62.2M | $83.7M | $82.6M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $51.5M | $80.7M | $67.8M | $90.2M | $88.8M | |
| Common Stock | $3M | $3.2M | $2.9M | $2.8M | $2.7M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $99.7M | $162.2M | $206.7M | $261M | $359.4M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $191.6K | $401.7K | $647.6K | $517.2K | $497.4K | |
| Total Equity | $99.9M | $162.6M | $207.3M | $261.5M | $359.9M | |
| Total Liabilities and Equity | $151.4M | $243.3M | $275.1M | $351.7M | $448.7M | |
| Cash and Short Terms | $102.8M | $167.3M | $208.1M | $269.5M | $361.4M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $99.9M | $99.4M | $75.3M | $153.6M | $153.1M | |
| Short Term Investments | $47M | $90.8M | $130M | $178.4M | $243.5M | |
| Accounts Receivable, Net | $47.5M | $69M | $55.1M | $60.1M | $50.7M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $2.4M | $1.7M | $2M | $2.2M | $3.7M | |
| Other Current Assets | $972.1K | $3.3M | $1.7M | $4.3M | $3M | |
| Total Current Assets | $197.8M | $264.3M | $264.3M | $398.6M | $454.4M | |
| Property Plant And Equipment | $6.2M | $8.7M | $6.9M | $8M | $5.5M | |
| Long-Term Investments | $1.5M | $2M | $2.4M | $1.3M | $1.2M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $4.5M | $1.3M | $1.1M | $4.6M | $6.5M | |
| Total Assets | $218.1M | $279.8M | $278.1M | $420.4M | $476.4M | |
| Accounts Payable | $48.5M | $47.7M | $43.1M | $56.8M | $38.1M | |
| Accrued Expenses | $1M | $1.1M | $955.5K | $1.2M | $2.2M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $2.2M | $2.5M | $2.5M | $3.1M | $2.1M | |
| Total Current Liabilities | $70.5M | $68.1M | $62.3M | $86.3M | $63.4M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $77.7M | $73.4M | $66.3M | $91.7M | $69.7M | |
| Common Stock | $3M | $2.9M | $2.4M | $2.6M | $2.7M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $416.4K | $648.4K | $510.3K | $515.7K | $496K | |
| Total Equity | $140.5M | $206.4M | $211.8M | $328.7M | $406.7M | |
| Total Liabilities and Equity | $218.1M | $279.8M | $278.1M | $420.4M | $476.4M | |
| Cash and Short Terms | $146.9M | $190.2M | $205.3M | $331.9M | $396.7M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $34.1M | $52.8M | $57.6M | $64.5M | $101M | |
| Depreciation & Amoritzation | $3.1M | $4.1M | $5.5M | $5.5M | $5.9M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $26.1M | -$24.5M | $3.9M | -$29M | -$1.1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $22.6M | $58.9M | $64.8M | $76.4M | $101.3M | |
| Capital Expenditures | $2M | $3.1M | $3.7M | $2.2M | $4.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$27.9M | -$30.4M | -$72.1M | -$17.4M | -$89.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$1.7M | -$2.4M | -$3.2M | -$3M | -$3.1M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $298.6K | $291.8K | $298.8K | -- | -- | |
| Cash From Financing | -$1.4M | -$2.1M | -$2.9M | -$3M | -$3.1M | |
| Beginning Cash (CF) | $73.8M | $67M | $96.7M | $77M | $130M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$6.7M | $26.4M | -$10.1M | $56M | $9M | |
| Ending Cash (CF) | $68.2M | $93.3M | $86.6M | $132M | $140.9M | |
| Levered Free Cash Flow | $20.6M | $55.8M | $61.1M | $74.2M | $96.9M | |
| Period Ending | 2020-12-23 | 2021-12-23 | 2022-12-23 | 2023-12-23 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-23 | 2021-12-23 | 2022-12-23 | 2023-12-23 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2021-12-23 | 2022-12-23 | 2023-12-23 | 2024-12-23 | 2025-12-23 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get GRVY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GRVY
Sector
P/E ratio
6.92x
16.53x
PEG ratio
0.28x
0.01x
P/B ratio
1.06x
1.42x
Price / LTM sales
1.12x
0.94x
Growth Metrics
GRVY
Sector
Revenue growth
-29.37%
-0.19%
Earnings growth
-25.1%
0.38%
Revenue (5-year growth)
16.37%
1.77%
Earnings forecast
--
$0.15
Profitability
GRVY
Sector
Profitability FY 2023
$184.1M
$343.9M
Return on invested capital
17.02%
0.94%
Return on assets
13.95%
0.07%
Return on equity
17.02%
2.62%
Earnings Date
Last Earnings Date
Nov
12
Next Earnings Date
Feb
14
Estimated Next Earnings Date
Feb
11
Balance Sheet
GRVY
Sector
Total cash
$396.7M
$115M
Short term investments
$218.6M
$67.8M
Total assets
$448.7M
$1B
Long term debt
--
$54.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
